AN OVERVIEW OF MATERNAL TOXICITY AND PRENATAL DEVELOPMENT - CONSIDERATIONS FOR DEVELOPMENTAL TOXICITY HAZARD ASSESSMENTS

被引：72

作者：

CHERNOFF, N

ROGERS, JM

KAVLOCK, RJ

机构：

来源：

关键词：

D O I：

10.1016/0300-483X(89)90050-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：111 / 125

页数：15

共 77 条

[11] DEWEY WL, 1975, METHODS NARCOTIC RES, P101
[12] EUKER JS, 1973, J REPROD FERTIL, V34, P343
[13] REDUCTION IN FREQUENCY OF FETOPATHIC EFFECTS OF CAFFEINE IN MICE BY PRETREATMENT WITH PROPRANOLOL
FUJII, T
NISHIMURA, H
[J]. TERATOLOGY, 1974, 10 (02) : 149 - 152
[14] GEBER WF, 1966, J EMBRYOL EXP MORPH, V16, P1
[15] GEBER WF, 1967, BIOL NEONATORUM, V11, P209
[16] GOLDMAN AS, 1963, J PHARMACOL EXP THER, V142, P351
[17] ABNORMALITIES OF PREGNANCY AS A FUNCTION OF ANXIETY AND LIFE STRESS
GORSUCH, RL
KEY, MK
[J]. PSYCHOSOMATIC MEDICINE, 1974, 36 (04): : 352 - 362
[18] HACKMAN RM, 1984, DRUGS NUTRIENTS INTE, P299
[19] COMPARATIVE TERATOGENICITY OF PHENYTOIN AMONG SEVERAL INBRED STRAINS OF MICE
HANSEN, DK
HODES, ME
[J]. TERATOLOGY, 1983, 28 (02) : 175 - 179
[20] ALTERATIONS IN MATERNAL PLASMA-CORTICOSTERONE LEVELS FOLLOWING TREATMENT WITH PHENYTOIN
HANSEN, DK
HOLSON, RR
SULLIVAN, PA
GRAFTON, TF
[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1988, 96 (01) : 24 - 32